These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34048883)

  • 1. Structure-property and structure-activity relationships of phenylferrocene derivatives as androgen receptor antagonists.
    Ochiai K; Fujii S
    Bioorg Med Chem Lett; 2021 Aug; 46():128141. PubMed ID: 34048883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Development of Androgen Receptor Antagonists Using Phenylferrocene Framework as a Hydrophobic Pharmacophore.
    Ochiai K; Yonezawa R; Fujii S
    ChemMedChem; 2024 Mar; 19(6):e202400040. PubMed ID: 38291942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
    Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
    Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of androgen receptor antagonists containing a pentafluorosulfanyl (SF
    Jin J; Zhou Y; Yang D; Zhang Q; Wang MW; Lu W
    Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800175. PubMed ID: 30318752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
    Inoue K; Urushibara K; Kanai M; Yura K; Fujii S; Ishigami-Yuasa M; Hashimoto Y; Mori S; Kawachi E; Matsumura M; Hirano T; Kagechika H; Tanatani A
    Eur J Med Chem; 2015 Sep; 102():310-9. PubMed ID: 26295173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of second-generation tropanol-based androgen receptor modulators.
    Sundén H; Holland MC; Poutiainen PK; Jääskeläinen T; Pulkkinen JT; Palvimo JJ; Olsson R
    J Med Chem; 2015 Feb; 58(3):1569-74. PubMed ID: 25646649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, docking, machine learning and antiproliferative activity of the 6-ferrocene/heterocycle-2-aminopyrimidine and 5-ferrocene-1H-Pyrazole derivatives obtained by microwave-assisted Atwal reaction as potential anticancer agents.
    Filho EV; Pina JWS; Antoniazi MK; Loureiro LB; Ribeiro MA; Pinheiro CB; Guimarães CJ; de Oliveira FCE; Pessoa C; Taranto AG; Greco SJ
    Bioorg Med Chem Lett; 2021 Sep; 48():128240. PubMed ID: 34217828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
    Peter S; Aderibigbe BA
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists.
    Lao K; Xun G; Gou X; Xiang H
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1597-1606. PubMed ID: 31469015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
    Kazui Y; Fujii S; Yamada A; Ishigami-Yuasa M; Kagechika H; Tanatani A
    Bioorg Med Chem; 2018 Oct; 26(18):5118-5127. PubMed ID: 30228001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review.
    Li L; Ma L; Sun J
    Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist.
    Andavar S; Vaithilingam M; Selvaraj D; Kumaran AA; Devanathan K
    Anticancer Agents Med Chem; 2020; 20(1):84-93. PubMed ID: 31755396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
    Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
    Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system.
    Gong G; Cao Y; Qian H; Zhou Y; Zhao H; Li L; Wang F; Zhao G
    Chem Commun (Camb); 2018 Jul; 54(60):8312-8315. PubMed ID: 29868665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists.
    Xu X; Du Q; Meng Y; Li Z; Wu H; Li Y; Zhao Z; Ge R; Lu X; Xue S; Chen X; Yang Y; Wang J; Bian J
    Eur J Med Chem; 2020 Apr; 192():112196. PubMed ID: 32169785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel androgen receptor degrading agents to treat advanced prostate cancer.
    Wu H; Ren J; Zhao L; Li Z; Ye W; Yang Y; Wang J; Bian J
    Eur J Med Chem; 2021 May; 217():113376. PubMed ID: 33756125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
    Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.
    Sexton KE; Barrett S; Bridgwood K; Carroll M; Dettling D; Du D; Fakhoury S; Fedij V; Hu LY; Kostlan C; Pocalyko D; Raheja N; Smith Y; Shanmugasundaram V; Wade K
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5230-3. PubMed ID: 21831636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
    Chen H; Yu YZ; Tian XM; Wang CL; Qian YN; Deng ZA; Zhang JX; Lv DJ; Zhang HB; Shen JL; Yuan M; Zhao SC
    Bioorg Med Chem; 2019 Jan; 27(1):133-143. PubMed ID: 30482547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Polycondensed Partly Saturated β-Carbolines Including Ferrocene Derivatives: Synthesis, DFT-Supported Structural Analysis, Mechanism of Some Diastereoselective Transformations and a Preliminary Study of Their in vitro Antiproliferative Effects.
    Fodor KJ; Hutai D; Jernei T; Takács A; Szász Z; Sulyok-Eiler M; Harmat V; Oláh Szabó R; Schlosser G; Hudecz F; Kőhidai L; Csámpai A
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.